etoposide has been researched along with Neoplasms, Bone Marrow in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T | 1 |
| Fujimoto, M; Maruyama, H; Okiyama, N; Saito, A; Tanaka, R | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Fujino, A; Honna, T; Kumagai, M; Kuroda, T; Masaki, H; Matsuoka, K; Morikawa, N; Nakagawa, A; Saeki, M | 1 |
| Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 1 |
| Dirnhofer, S; Girsberger, S; Karow, A; Lehmann, T; Lundberg, P; Passweg, JR; Rovó, A; Skoda, R; Tichelli, A | 1 |
| Eckschlager, T; Groh, T; Hrabeta, J; Poljakova, J; Stiborova, M | 1 |
| Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
| Burdach, S; Dunst, J; Finke, R; Gadner, H; Göbel, U; Haase, R; Haerting, J; Juergens, H; Laws, HJ; Metzner, B; Meyer-Bahlburg, A; Pape, H; van Kaik, B; Wawer, A | 1 |
| Debatin, KM; Fulda, S; Hotfilder, M; Poremba, C; Schäfer, KL; Truckenbrod, B; Van Valen, F; Winkelmann, W | 1 |
| Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B | 1 |
| Sugiura, H; Suzuki, Y; Takahashi, M; Yamada, K | 1 |
| Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL | 1 |
| Cheung, NK; Kramer, K; Kushner, BH | 1 |
| Bergman, GF; Blumberg, JB; Carlson, JL; Furr, CE; Galloway, JR; Griffith, DP; Jonas, CR; Jones, DP; Puckett, AB; Szeszycki, EE; Tyre, C; Ziegler, TR | 1 |
| Bondiau, PY; Foa, C; Magné, N; Otto, J; Thyss, A | 1 |
| Kushner, BH; Meyers, PA | 1 |
| Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH | 1 |
| Beck, JD; Greil, J; Hertzberg, H; Kremens, B; Velten, I | 1 |
3 review(s) available for etoposide and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine | 2018 |
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Retrospective Studies; Salvage Therapy; Soft Tissue Neoplasms; Young Adult | 2013 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation | 2001 |
4 trial(s) available for etoposide and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Killer Cells, Natural; Leucovorin; Lung Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms; Treatment Outcome | 2003 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine | 2004 |
Oral etoposide for refractory and relapsed neuroblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Treatment Outcome | 1999 |
Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Ascorbic Acid; Bone Marrow Neoplasms; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Etoposide; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Middle Aged; Parenteral Nutrition, Total; Vitamin E; Zinc | 2000 |
12 other study(ies) available for etoposide and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
A Case of Refractory Subcutaneous Panniculitis-like T-cell Lymphoma with Bone Marrow and Lung Involvement Treated Successfully with Oral Etoposide.
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Biopsy; Bone Marrow Neoplasms; Etoposide; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell; Male; Panniculitis; Treatment Outcome | 2018 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Neoplastic Cells, Circulating; Neuroblastoma; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Vincristine | 2008 |
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Topics: Alleles; Antineoplastic Agents; Bone Marrow Neoplasms; Drug Therapy, Combination; Etoposide; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mutation; Myeloproliferative Disorders; Pancreatic Neoplasms | 2013 |
Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Neoplasms; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Neuroblastoma; Risk Factors; Valproic Acid | 2012 |
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation | 2003 |
Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Cells; Bone Marrow Neoplasms; Cell Survival; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Membrane Glycoproteins; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2003 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neuroblastoma; Paraplegia; Retroperitoneal Neoplasms; Skull Neoplasms; Vincristine | 2004 |
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Keratins; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; Retrospective Studies; Sensitivity and Specificity | 1996 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Diagnosis, Differential; Disseminated Intravascular Coagulation; Etoposide; Female; Fluorouracil; Hemorrhagic Disorders; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Precancerous Conditions; Stomach; Stomach Neoplasms; Thrombocytopenia | 2000 |
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Remission Induction; Retinoblastoma; Thiotepa; Transplantation, Autologous; Vincristine | 2001 |